Literature DB >> 16815872

Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A.

Thomas M Bosley1, Darren T Oystreck, Richard L Robertson, Abdulaziz al Awad, Khaled Abu-Amero, Elizabeth C Engle.   

Abstract

Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a complex strabismus syndrome that results from mutations in the homeodomain transcription factor PHOX2A. To define the clinical and neuroimaging features of patients with this autosomal recessive syndrome, we studied 15 patients with genetically defined CFEOM2. All patients underwent full neurological, neuro-ophthalmological and orthoptic assessments. Twelve patients had pupillary pharmacological testing and nine had 3.0 tesla MRI of the brain, brainstem and orbits. Patients were born with severe bilateral ptosis and exotropia with almost complete bilateral absence of adduction, elevation, depression and intorsion. Variable abduction was present prior to strabismus surgery in 14 patients, and central ocular motility reflexes (smooth pursuit, saccades, vestibulo-ocular reflex and optokinetic reflex) were intact except for convergence. Pupillary light and near reflexes were not present, but irises were anatomically normal and responded to pupillary pharmacology. Neuroimaging of brain and brainstem was remarkable for the anatomical absence of cranial nerve (CN) 3 and probably CN 4 bilaterally. Therefore, the CFEOM2 phenotype and neuroimaging are both consistent with the congenital absence of CNs 3 and 4. Additional features included presence of most central ocular motility reflexes, a central lack of pupillary responsiveness of uncertain aetiology and modest phenotypic variability that does not correlate with specific PHOX2A mutations. Clinical presentation, neuroimaging and Phox2a-/- animal models all support the concept that CFEOM2 is a primary neurogenic abnormality with secondary myopathic changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815872     DOI: 10.1093/brain/awl161

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  20 in total

Review 1.  The genetic basis of incomitant strabismus: consolidation of the current knowledge of the genetic foundations of disease.

Authors:  Carolyn P Graeber; David G Hunter; Elizabeth C Engle
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

Review 2.  Recent progress in understanding congenital cranial dysinnervation disorders.

Authors:  Darren T Oystreck; Elizabeth C Engle; Thomas M Bosley
Journal:  J Neuroophthalmol       Date:  2011-03       Impact factor: 3.042

3.  Miosis in a case of congenital fibrosis of extraocular muscles: a rare presentation of a rare disease.

Authors:  Payal Gupta; Brijesh Takkar; Radha Sarawagi; Hameed Obedulla
Journal:  BMJ Case Rep       Date:  2019-03-20

4.  Living and working abroad as a neurologist.

Authors:  Thomas M Bosley
Journal:  Neurol Clin Pract       Date:  2012-12

Review 5.  Congenital innervation dysgenesis syndrome (CID)/congenital cranial dysinnervation disorders (CCDDs).

Authors:  A A Assaf
Journal:  Eye (Lond)       Date:  2011-07-01       Impact factor: 3.775

Review 6.  Diffusion tensor imaging and fiber tractography in brain malformations.

Authors:  Andrea Poretti; Avner Meoded; Andrea Rossi; Charles Raybaud; Thierry A G M Huisman
Journal:  Pediatr Radiol       Date:  2013-01-04

7.  PHOX2A regulation of oculomotor complex nucleogenesis.

Authors:  Khaleda B Hasan; Seema Agarwala; Clifton W Ragsdale
Journal:  Development       Date:  2010-04       Impact factor: 6.868

Review 8.  Gaskell revisited: new insights into spinal autonomics necessitate a revised motor neuron nomenclature.

Authors:  Bernd Fritzsch; Karen L Elliott; Joel C Glover
Journal:  Cell Tissue Res       Date:  2017-08-31       Impact factor: 5.249

Review 9.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

10.  MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR.

Authors:  Rong Wang; Xiaofeng Chen; Tongpeng Xu; Rui Xia; Liang Han; Wenming Chen; Wei De; Yongqian Shu
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.